Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Old West Investment Management's investment thesis on Bruker Biosciences Corp. ($BRKR) — Q2 2026 | Buyside Digest

All Pitches

View Letter Analysis

$BRKRNASDAQBruker Biosciences Corp.

NEUTRAL

Old West Investment Management—BRKR

Fund Letter

Q2 2026

Published August 26, 2026

View Fund Profile

$57.08USD

-2.4% vs last month

$57.08Pitched

-0.0% since pitch

Market Cap$7.8B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

Old West All Cap Opportunity returned -0.94% net in Q2 2026 but is up 14.92% year-to-date. The manager believes...

— Old West Investment Management

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $BRKR, and what else Old West Investment Management is buying.

Other pitches on $BRKR

Other investors who've written on Bruker Biosciences Corp.

BBH Select Series - Mid Cap FundBULL

Pitched Mar 31, 2025

This scientific instruments provider is navigating temporary headwinds from delayed Chinese stimulus, a slow biopharma recovery, and potential academic funding cuts. However, its broad...

View all $BRKR pitches →